The Ohio State University

  • Carcinoma, Hepatocellular
  • Hepatitis, Autoimmune
  • Liver Transplantation

Advances in Liver Disease

This webcast will discuss Advances in Liver Disease. Viewers should expect to understand the scope of steatotic liver disease and the increasing burden on the current healthcare system. The program will discuss management of steatotic liver disease including novel pharmacologic treatment options; discuss new first line systemic therapy options for patients with unresectable hepatocellular carcinoma; introduce the changing landscape of hepatocellular carcinoma management including combination therapy, novel biomarkers, and the role of liver transplantation; and discuss recent advances in autoimmune hepatitis and a potential new first line therapy option.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

The webcasts are free to view.Free
viewers must pay $25 to access the posttest if they are not a member of one of our subscribing hospitals or affiliated with OSU or OSUWMC$25

Listed by the provider · ccme.osu.edu

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Free to view · $25 for credit
  • Released
    Jun 14, 2024
  • Last day to claim credit
    Jun 14, 2027 8 months left